Cornerstone Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Cornerstone Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$601K	Buy	1,223 +611	+100%	+$332K	0.03%	404
2025 Q4	$355K	Sell	612 -10	-2%	-$5.66K	0.02%	503
2025 Q3	$302K	Buy	622 +15	+2%	+$6.98K	0.02%	527
2025 Q2	$246K	Buy	607 +31	+5%	+$13K	0.01%	566
2025 Q1	$287K	Sell	576 -154	-21%	-$83.4K	0.02%	486
2024 Q4	$380K	Buy	730 +101	+16%	+$55.5K	0.03%	416
2024 Q3	$389K	Sell	629 -20	-3%	-$11.8K	0.03%	404
2024 Q2	$359K	Buy	649 +51	+9%	+$29.2K	0.03%	398
2024 Q1	$348K	Sell	598 -62	-9%	-$34.8K	0.03%	403
2023 Q4	$350K	Sell	660 -44	-6%	-$21.3K	0.03%	389
2023 Q3	$356K	Buy	704 +16	+2%	+$8.53K	0.03%	384
2023 Q2	$359K	Sell	688 -1	-0.1%	-$540	0.03%	367
2023 Q1	$397K	Buy	+689	New	+$388K	0.04%	325
2022 Q3	$699K	Buy	1,379 +18	+1%	+$10.1K	0.08%	205
2022 Q2	$739K	Buy	1,361 +394	+41%	+$217K	0.08%	197
2022 Q1	$571K	Sell	967 -120	-11%	-$68.9K	0.06%	257
2021 Q4	$725K	Buy	1,087 +359	+49%	+$224K	0.07%	231
2021 Q3	$416K	Buy	728 +20	+3%	+$11K	0.04%	301
2021 Q2	$357K	Buy	708 +99	+16%	+$46.7K	0.04%	344
2021 Q1	$278K	Sell	609 -88	-13%	-$42K	0.03%	366
2020 Q4	$325K	Buy	697 +139	+25%	+$65.2K	0.04%	319
2020 Q3	$247K	Buy	+558	New	+$231K	0.04%	338
2019 Q2	–	Sell	-524	Closed	-$250K	–	494
2019 Q1	$250K	Buy	+524	New	+$130K	0.03%	435
2018 Q4	–	Sell	-69,468	Closed	-$359K	–	1073
2018 Q3	$359K	Buy	69,468 +3,133	+5%	+$721K	﹤0.01%	1013
2018 Q2	$322K	Buy	+66,335	New	+$14.1M	﹤0.01%	1168

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cornerstone Wealth Management's TMO Position: Q1 2026 in Review

Cornerstone Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 100% in Q1 2026, buying an estimated $332K and bringing the position to 1,223 shares worth $601K. The position accounts for 0.03% of the portfolio, ranked #404.

Cornerstone Wealth Management first reported a position in TMO in Q2 2018 and has held it in 25 quarters since. The position peaked at $739K in Q2 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Cornerstone Wealth Management held 1,223 shares of Thermo Fisher Scientific worth $601K as of Q1 2026.
Cornerstone Wealth Management bought 611 Thermo Fisher Scientific shares in Q1 2026, an estimated $332K.
Thermo Fisher Scientific made up 0.03% of Cornerstone Wealth Management's portfolio in Q1 2026, its #404 holding.
Cornerstone Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2018 and has held it in 25 quarters since.
Cornerstone Wealth Management's Thermo Fisher Scientific position peaked at $739K in Q2 2022.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cornerstone Wealth Management's 13F filing for Q1 2026, filed 24 Apr 2026.